newsfilter
← Latest News
GlobeNewswire·

Dyne Therapeutics to Participate in Upcoming Investor Conference

  • Dyne Therapeutics, Inc. (Nasdaq: DYN) will participate in the Jefferies Global Healthcare Conference fireside chat on Monday, November 16, 2026, at 2:30 p.m. GMT (9:30 a.m. ET) in London.
  • A live webcast of the event will be available in the Investors & Media section of Dyne's website, with a replay accessible for 90 days.
  • The company focuses on delivering functional improvement for people with genetically driven neuromuscular diseases by targeting muscle & the central nervous system (CNS).
  • Dyne is advancing clinical programs for Duchenne muscular dystrophy (DMD) & myotonic dystrophy type 1 (DM1), alongside preclinical programs for facioscapulohumeral muscular dystrophy (FSHD), Pompe disease, & multiple DMD mutations.
  • Investor inquiries can be directed to Mia Tobias at ir@dyne-tx.com or 781-317-0353.
  • Media inquiries can be directed to Stacy Nartker at media@dyne-tx.com or 781-317-1938.
Company
Dyne Therapeutics, Inc.
Keywords
Nasdaq:DYN, Dyne Therapeutics, Inc.